Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06382948
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-04-05
Brief Title:
Elacestrant Everolimus in Patients ERHER2- ESR1mut Advanced Breast Cancer Progressing to ET and CDK46i
Sponsor:
MedSIR
Organization:
MedSIR
Organization Data
Organization:
MedSIR
Class:
OTHER
Study ID:
MedOPP545
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedSIR
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Stemline Therapeutics Inc | OTHER |